Trojan Bio Alternatives & Competitors
7 companies similar to Trojan Bio — Harnessing viral specific immunity for fighting cancer
Companies similar to Trojan Bio
Transgene
Immunotherapy against cancer. 4 clinical-stage products. 2 novel platforms: Invir.IO™ and...
Biolojic Design, Ltd.
Biolojic Design is a biopharmaceutical company dedicated to the development of human antib...
biosyn Arzneimittel GmbH
biosyn Arzneimittel GmbH is a pharmaceutical company promoting immune health in Germany's...
BioInvent International AB
BioInvent is translating cancer antibody biology into innovative immuno-oncology therapies...
Track all Trojan Bio competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
NorthStar Medical Radioisotopes, LLC
Our Mission: Providing Patients Global Access to Game-Changing Radiopharmaceuticals
ARECHAR
Pharmaceutical Manufacturers | Nutraceuticals Manufacturers | FDF | Cancer,Pulmonology, HI...
Patheon
An integrated CDMO partner for every step in your drug development journey
About Trojan Bio
Trojan Bio is an Israeli startup founded in 2021, specializing in harnessing viral specific immunity for fighting cancer. The company's slogan, "Harnessing viral specific immunity for fighting cancer," encapsulates its mission to develop a novel class of therapeutic antibodies for treating various cancers. Trojan Bio's...
Immunotherapy, Cancer Treatment, Therapeutic Antibodies, Viral Peptides, Immune System Activation, Pre-clinical Research, Cancer Eradication, Oncology, Viral-specific Immunity
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Trojan Bio and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Trojan Bio on 12 Sep 2024. The 7 companies listed here were last checked between 12 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.